Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Collegium Pharma (NQ: COLL )

32.36 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

2005 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
September 13, 2005
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 02, 2005
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 02, 2005
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
August 02, 2005

2004 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
September 06, 2004
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
June 08, 2004
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
March 10, 2004
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
January 21, 2004

2003 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
September 03, 2003
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
June 09, 2003
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
February 26, 2003
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
January 20, 2003

2002 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
September 09, 2002
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
June 12, 2002
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
March 13, 2002

2001 Reports

Form 10-K: Annual Corporate Report
Source: SEC/Edgar
December 25, 2001
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
September 11, 2001
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 20, 2001
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
March 14, 2001
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
January 10, 2001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.